Prof. Jeremy Chataway
Professor Jeremy Chataway MA, PhD, FRCP Consultant Neurologist National Hospital for Neurology and Neurosurgery (NHNN), Queen Square, University College Foundation NHS Trust and Professor of Neurology, University College London.
After qualifying in medicine at Cambridge and Oxford Universities, and general medical training in London, he specialised in Neurology with posts in Edinburgh, Cambridge and London. He was awarded a PhD from Cambridge University in genetic epidemiology of multiple sclerosis and took up his post as a consultant Neurologist in 2001 at The National Hospital for Neurology and Neurosurgery, Queen Square, University College Foundation NHS Trust, London.
His clinical interest at UCLH is multiple sclerosis (MS), where he was the clinical lead until recently for over >5000 patients with MS.
He has a particular interest in advanced clinical trial design in Progressive MS and was the Chief Investigator (CI) of the MS-STAT1 trial in secondary progressive MS, using high dose simvastatin; and is the CI of the MS-SMART (recently published*) and MS-STAT2 (still recruiting) trials in secondary progressive MS. He works closely with the MRC Clinical Trials Unit and the UK MS Society.
Separately, he was a Founder member of the Queen Square Adult Onset Leukodystrophy Group, studying rare white matter disorders.
*MS-SMART trial: Lancet Neurology Jan 2020 https://doi.org/10.1016/S1474-4422(19)30485-5